Association of Inflammatory and Metabolic Biomarkers with Lifestyle-Related Diseases in the Community Population
Inflammatory and Metabolic Biomarkers in Lifestyle-Related Diseases
DOI:
https://doi.org/10.69750/dmls.03.04.0204Keywords:
Inflammatory biomarkers, Metabolic syndrome, hs-CRP, Lifestyle diseases, Dyslipidemia, Cardiometabolic riskAbstract
Background: Chronic inflammation and metabolic dysfunction are closely linked to lifestyle-related diseases such as obesity, hypertension, diabetes mellitus, dyslipidemia, and metabolic syndrome, which are rapidly rising all over the world. Inflammatory and metabolic markers can be useful to identify early those who are at greater cardiometabolic risk.
Objective: To assess the relationship between inflammatory and metabolic biomarkers and lifestyle-related diseases in the community.
Methods: This cross-sectional community-based study was conducted from March 2023 to September 2025 at the Department of Medicine, Punjab Medical College, Faisalabad, Pakistan, and Sharif Medical and Dental College, Lahore, Pakistan. A total of 200 participants aged 20–70 years were enrolled using non-probability consecutive sampling. Structured questionnaires were used to collect anthropometric measurements and lifestyle-related data. The blood samples were used to determine high-sensitivity C-reactive protein (hs-CRP), fasting blood glucose, glycated hemoglobin (HbA1c), lipid profile, and serum uric acid.
Results: Among 200 participants, 112 (56.0%) were females, and 88 (44.0%) were males. Obesity was observed in 39.5%, hypertension in 36.5%, diabetes mellitus in 30.5%, dyslipidemia in 46.0%, and metabolic syndrome in 34.0% of participants. Mean hs-CRP levels were significantly higher among diseased participants (6.1 ± 1.7 mg/L) compared to healthy individuals (2.2 ± 0.8 mg/L; p<0.001). In addition, the HbA1c, triglycerides, LDL-C, fasting blood glucose, and serum uric acid levels were also significantly increased among individuals with lifestyle-related diseases. A high level of hs-CRP was most strongly and independently associated with metabolic syndrome.
Conclusion: There is a strong correlation between inflammatory and metabolic markers and lifestyle-related diseases, and they can be useful markers for early recognition of cardiometabolic diseases.
Downloads
References
Ferreira LDNM, Fisberg RM, Sarti FM, Rogero MM. Association between inflammatory and metabolic biomarkers and common mental disorders among adults: 2015 Health Survey of São Paulo, SP, Brazil. Metabolites. 2024;14(10):535. doi:10.3390/metabo14100535.
Kuring JK, Mathias JL, Ward L, Tachas G. Inflammatory markers in persons with clinically significant depression, anxiety, or PTSD: a systematic review and meta-analysis. J Psychiatr Res. 2023;168:279-292. doi:10.1016/j.jpsychires.2023.10.009.
Thylur DS, Goldsmith DR. Brick by brick: building a transdiagnostic understanding of inflammation in psychiatry. Harv Rev Psychiatry. 2022;30:40-53. doi:10.1097/HRP.0000000000000326.
Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci. 2019;1437:57-67. doi:10.1111/nyas.13712.
Angiulli F, Conti E, Zoia CP, Da Re F, Appollonio I, Ferrarese C, et al. Blood-based biomarkers of neuroinflammation in Alzheimer’s disease: a central role for periphery? Diagnostics (Basel). 2021;11:1525. doi:10.3390/diagnostics11091525.
Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22-34. doi:10.1038/nri.2015.5.
Hasheminasabgorji E, Jha JC. Dyslipidemia, diabetes, and atherosclerosis: role of inflammation and ROS-redox-sensitive factors. Biomedicines. 2021;9:1602. doi:10.3390/biomedicines9111602.
Hotamisligil GS. Inflammation, metaflammation, and immunometabolic disorders. Nature. 2017;542:177-185. doi:10.1038/nature21363.
Stein DJ, Benjet C, Gureje O, Lund C, Scott KM, Poznyak V, et al. Integrating mental health with other non-communicable diseases. BMJ. 2019;364:l295. doi:10.1136/bmj.l295.
Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645. doi:10.1161/CIRCULATIONAHA.109.192644.
Lin S, Pan J, Zhu X, Lan R, Sun X, Shen R, et al. Associations of metabolic indicators and inflammation-related indices with adverse cardiovascular events in US adults: NHANES 1999-2018. Lipids Health Dis. 2026;25(1):57. doi:10.1186/s12944-026-02866-w.
Tian X, Chen S, Zuo Y, Zhang Y, Zhang X, Xu Q, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident cardiovascular disease. BMC Med. 2022;20(1):383. doi:10.1186/s12916-022-02592-x.
Šebeková K, Staruchová M, Mišľanová C, Líšková A, Horváthová M, Tulinská J, et al. Association of inflammatory and oxidative status markers with metabolic syndrome and its components in 40-to-45-year-old females: a cross-sectional study. Antioxidants (Basel). 2023;12(6):1221. doi:10.3390/antiox12061221.
Cho SMJ, Lee H, Shim JS, Jeon JY, Kim HC. Association between physical activity and inflammatory markers in community-dwelling, middle-aged adults. Appl Physiol Nutr Metab. 2021;46(7):828-836. doi:10.1139/apnm-2020-1069.
Dehghani Firouzabadi F, Jayedi A, Asgari E, Akbarzadeh Z, Janbozorgi N, Djafarian K, et al. Association of dietary and lifestyle inflammation score with metabolic syndrome in a sample of Iranian adults. Front Nutr. 2021;8:735174. doi:10.3389/fnut.2021.735174.
Dugani SB, Moorthy MV, Li C, Demler OV, Alsheikh-Ali AA, Ridker PM, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiol. 2021;6(4):437-447. doi:10.1001/jamacardio.2020.7073.
Carrasco-Marín F, Zhao L, Hébert JR, Wirth MD, Petermann-Rocha F, Phillips N, et al. Association of a dietary inflammatory index with cardiometabolic, endocrine, liver, renal, and bone biomarkers: cross-sectional analysis of the UK Biobank study. Nutr Metab Cardiovasc Dis. 2024;34(7):1731-1740. doi:10.1016/j.numecd.2024.03.010.
Farmanfarma KK, Kaykhaei MA, Adineh HA, Mohammadi M, Dabiri S, Ansari-Moghaddam A. Prevalence of metabolic syndrome in Iran: a meta-analysis of 69 studies. Diabetes Metab Syndr. 2019;13:792-799. doi:10.1016/j.dsx.2018.11.055.
Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bulló M, Couture P, Covas MI, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. Nutr Rev. 2017;75:307-326. doi:10.1093/nutrit/nux014.
Zhu Z, Wu F, Lu Y, Wu C, Wang Z, Zang J, et al. Total and nonheme dietary iron intake is associated with metabolic syndrome and its components in Chinese men and women. Nutrients. 2018;10:1663. doi:10.3390/nu10111663.
Downloads
Published
Issue
Section
License
© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License , which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third-party material in this article are included in the article’s Creative Commons license unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you must obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ . The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/ ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.














